Who owns Caribou Biosciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CRBU from SEC Form 13F filings across 147 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 147 institutions disclosed 53.6M shares of Caribou Biosciences, Inc. worth $67.9M — about 49.8% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
147
13F holders
$67.9M
value, 2026 filers
49.8%
of shares outstanding (53.6M sh)
26
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CRBU's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 8.1M | $10.3M | 0.0% | 7.6% | +4.2% |
| 2 | Pfizer Inc | 4.7M | $5.8M | 3.5% | 4.4% | 0.0% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.4M | $5.6M | 0.0% | 4.1% | +5.2% |
| 4 | MACKENZIE FINANCIAL CORP | 4.1M | $5.2M | 0.0% | 3.8% | +11.5% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | 2.6M | $3.2M | 0.0% | 2.4% | -7.8% |
| 6 | Kynam Capital Management, LP | 2.5M | $3.2M | 0.2% | 2.3% | 0.0% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $3.1M | 0.0% | 2.3% | +2.7% |
| 8 | BANK OF AMERICA CORP /DE/ | 1.7M | $2.2M | 0.0% | 1.6% | +23.2% |
| 9 | AQR CAPITAL MANAGEMENT LLCNEW | 1.6M | $2.1M | 0.0% | 1.5% | new |
| 10 | STATE STREET CORP | 1.5M | $1.9M | 0.0% | 1.4% | -6.5% |
| 11 | ACADIAN ASSET MANAGEMENT LLC | 1.5M | $1.8M | 0.0% | 1.4% | -18.0% |
| 12 | Qube Research & Technologies Ltd | 1.1M | $1.4M | 0.0% | 1% | +105.2% |
| 13 | FMR LLC | 1.1M | $1.4M | 0.0% | 1% | +47.9% |
| 14 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 876,016 | $1.1M | 0.0% | 0.8% | +12.9% |
| 15 | UBS Group AG | 824,282 | $1.0M | 0.0% | 0.8% | +59.3% |
| 16 | GOLDMAN SACHS GROUP INC | 804,900 | $1.0M | 0.0% | 0.7% | +149.3% |
| 17 | DIMENSIONAL FUND ADVISORS LP | 748,734 | $950,730 | 0.0% | 0.7% | -23.2% |
| 18 | NORTHERN TRUST CORP | 729,297 | $926,207 | 0.0% | 0.7% | +2.3% |
| 19 | VANGUARD FIDUCIARY TRUST CO | 700,100 | $889,127 | 0.0% | 0.7% | +15.5% |
| 20 | TWO SIGMA INVESTMENTS, LP | 674,627 | $856,776 | 0.0% | 0.6% | -35.5% |
| 21 | MORGAN STANLEY | 665,754 | $845,507 | 0.0% | 0.6% | +448.8% |
| 22 | MAVERICK CAPITAL LTD | 652,542 | $828,728 | 0.0% | 0.6% | 0.0% |
| 23 | VANGUARD PORTFOLIO MANAGEMENT LLC | 624,788 | $793,481 | 0.0% | 0.6% | +1.8% |
| 24 | MARSHALL WACE, LLP | 575,216 | $730,528 | 0.0% | 0.5% | +53.1% |
| 25 | GSA CAPITAL PARTNERS LLP | 551,532 | $700,000 | 0.0% | 0.5% | +19.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.